FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3155579250> ?p ?o ?g. }

• W3155579250 endingPage "463" @default.
• W3155579250 startingPage "455" @default.
• W3155579250 abstract "Skeletal metastases (SM) in advanced pancreatic ductal adenocarcinoma (PDAC) is an infrequent occurrence that has been previously reported in literature to occur in less than 2.5% of the cases. Complications such as pathological fractures can result in intractable pain, immobilization and a significant deterioration in quality of life. The purpose of this study is to improve the understanding of the increasing incidence of SM and the importance of surveillance and adequate management of SM in these patients.A retrospective analysis was conducted using a clinical database at a single tertiary care institution for cancer patients; this included 207 patients with advanced PDAC diagnosed between December 2004 and March 2017 receiving palliative chemotherapy. SM were identified by computerized tomography (CT)/fluorodeoxyglucose positron emission tomography (FDG-PET)/magnetic resonance imaging (MRI). Information regarding demographics, clinical course and date of last follow-up/death were collected. After a median follow-up of 11 months, an analysis was conducted, including a Kaplan-Meier survival analysis.The study included 207 patients; 19 out of 207 patients (9.2%) developed SM; the primary tumor was located in the pancreatic body/tail in 12 out of 19 patients (63.2%). The thoracic and lumbar vertebrae were the most common sites of SM. Other common synchronous sites of metastases included the liver and lung. A majority of the lesions were osteolytic (63.2%). The median time of diagnosis from the initial diagnosis was 2 months (range, 0-60 months). Bone pain was observed as the initial symptom in 7 out of 19 patients (36.8%), 2 out of 19 patients (10.5%) had a pathological fracture and 1 out of 19 patients (5.3%) developed a para-spinal mass causing inferior vena cava compression. The median survival period for patients with SM was 11 months (range, 0-62 months) and for those without SM was 12 months (range, 0-147 months) [hazard ratio (HR) 1.24, 95% confidence interval (CI): 0.66-2.30, P=0.51].There has been a challenge with regards to management of the increasing number of patients with SM. Thoracic and lumbar vertebrae are the most common sites and pathological fractures in these sites can be catastrophic. Careful evaluation of skeletal signs and symptoms, early detection and intervention are essential to prevent morbidity and mortality from complications in patients with PDAC and SM." @default.
• W3155579250 created "2021-04-26" @default.
• W3155579250 creator A5003240554 @default.
• W3155579250 creator A5035103833 @default.
• W3155579250 creator A5055427410 @default.
• W3155579250 creator A5056021087 @default.
• W3155579250 creator A5057930138 @default.
• W3155579250 creator A5063133785 @default.
• W3155579250 creator A5065671989 @default.
• W3155579250 creator A5073353985 @default.
• W3155579250 date "2021-04-01" @default.
• W3155579250 modified "2023-10-06" @default.
• W3155579250 title "Skeletal metastases in advanced pancreatic ductal adenocarcinoma: a retrospective analysis" @default.
• W3155579250 cites W1931508686 @default.
• W3155579250 cites W1965387540 @default.
• W3155579250 cites W1977202592 @default.
• W3155579250 cites W2002343043 @default.
• W3155579250 cites W2011962920 @default.
• W3155579250 cites W2029189079 @default.
• W3155579250 cites W2047213964 @default.
• W3155579250 cites W2050410927 @default.
• W3155579250 cites W2050823098 @default.
• W3155579250 cites W2094523926 @default.
• W3155579250 cites W2111807012 @default.
• W3155579250 cites W2124270325 @default.
• W3155579250 cites W2125292670 @default.
• W3155579250 cites W2151253787 @default.
• W3155579250 cites W2158134441 @default.
• W3155579250 cites W2165480504 @default.
• W3155579250 cites W2166758293 @default.
• W3155579250 cites W2333862557 @default.
• W3155579250 cites W2412560176 @default.
• W3155579250 cites W53163 @default.
• W3155579250 doi "https://doi.org/10.21037/jgo-20-361" @default.
• W3155579250 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8107595" @default.
• W3155579250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34012639" @default.
• W3155579250 hasPublicationYear "2021" @default.
• W3155579250 type Work @default.
• W3155579250 sameAs 3155579250 @default.
• W3155579250 citedByCount "3" @default.
• W3155579250 countsByYear W31555792502022 @default.
• W3155579250 crossrefType "journal-article" @default.
• W3155579250 hasAuthorship W3155579250A5003240554 @default.
• W3155579250 hasAuthorship W3155579250A5035103833 @default.
• W3155579250 hasAuthorship W3155579250A5055427410 @default.
• W3155579250 hasAuthorship W3155579250A5056021087 @default.
• W3155579250 hasAuthorship W3155579250A5057930138 @default.
• W3155579250 hasAuthorship W3155579250A5063133785 @default.
• W3155579250 hasAuthorship W3155579250A5065671989 @default.
• W3155579250 hasAuthorship W3155579250A5073353985 @default.
• W3155579250 hasBestOaLocation W31555792501 @default.
• W3155579250 hasConcept C120665830 @default.
• W3155579250 hasConcept C121332964 @default.
• W3155579250 hasConcept C121608353 @default.
• W3155579250 hasConcept C126322002 @default.
• W3155579250 hasConcept C126838900 @default.
• W3155579250 hasConcept C141071460 @default.
• W3155579250 hasConcept C143409427 @default.
• W3155579250 hasConcept C167135981 @default.
• W3155579250 hasConcept C207886595 @default.
• W3155579250 hasConcept C2775842073 @default.
• W3155579250 hasConcept C2780210213 @default.
• W3155579250 hasConcept C2781182431 @default.
• W3155579250 hasConcept C61511704 @default.
• W3155579250 hasConcept C71924100 @default.
• W3155579250 hasConceptScore W3155579250C120665830 @default.
• W3155579250 hasConceptScore W3155579250C121332964 @default.
• W3155579250 hasConceptScore W3155579250C121608353 @default.
• W3155579250 hasConceptScore W3155579250C126322002 @default.
• W3155579250 hasConceptScore W3155579250C126838900 @default.
• W3155579250 hasConceptScore W3155579250C141071460 @default.
• W3155579250 hasConceptScore W3155579250C143409427 @default.
• W3155579250 hasConceptScore W3155579250C167135981 @default.
• W3155579250 hasConceptScore W3155579250C207886595 @default.
• W3155579250 hasConceptScore W3155579250C2775842073 @default.
• W3155579250 hasConceptScore W3155579250C2780210213 @default.
• W3155579250 hasConceptScore W3155579250C2781182431 @default.
• W3155579250 hasConceptScore W3155579250C61511704 @default.
• W3155579250 hasConceptScore W3155579250C71924100 @default.
• W3155579250 hasIssue "2" @default.
• W3155579250 hasLocation W31555792501 @default.
• W3155579250 hasLocation W31555792502 @default.
• W3155579250 hasLocation W31555792503 @default.
• W3155579250 hasOpenAccess W3155579250 @default.
• W3155579250 hasPrimaryLocation W31555792501 @default.
• W3155579250 hasRelatedWork W2003938723 @default.
• W3155579250 hasRelatedWork W2047967234 @default.
• W3155579250 hasRelatedWork W2118496982 @default.
• W3155579250 hasRelatedWork W2167175582 @default.
• W3155579250 hasRelatedWork W2275480158 @default.
• W3155579250 hasRelatedWork W2362760700 @default.
• W3155579250 hasRelatedWork W2364998975 @default.
• W3155579250 hasRelatedWork W2439875401 @default.
• W3155579250 hasRelatedWork W4238867864 @default.
• W3155579250 hasRelatedWork W2525756941 @default.
• W3155579250 hasVolume "12" @default.
• W3155579250 isParatext "false" @default.
• W3155579250 isRetracted "false" @default.

• next